Jump to content

Potential COVID-19 vaccine from China shows promise in animal tests


Recommended Posts

Posted

Potential COVID-19 vaccine from China shows promise in animal tests

 

2020-06-10T084523Z_1_LYNXMPEG590NW_RTROPTP_4_HEALTH-CORONAVIRUS-ASTRAZENECA.JPG

FILE PHOTO: Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

 

BEIJING (Reuters) - A potential COVID-19 vaccine being developed by Chinese researchers showed promise in trials in monkeys, triggering antibodies and raising no safety issues, researchers said, and a human trial with more than 1,000 participants is under way.

 

The vaccine candidate, called BBIBP-CorV, induced high-level neutralising antibodies that can block the virus from infecting cells in monkeys, rats, guinea pigs and rabbits, researchers said in a paper published in online by the medical journal Cell on Saturday.

 

"These results support the further evaluation of BBIBP-CorV in a clinical trial," researchers said in the paper. 

 

BBIBP-CorV, developed by Beijing Institute of Biological Products affiliated to state-owned China National Pharmaceutical Group (Sinopharm), is among five candidates China is testing in humans.

 

More than 100 potential COVID-19 vaccines are in various stages of development around the world. Among front runners currently in human trials are being developed by AstraZeneca, Pfizer, BioNtech, Johnson & Johnson, Merck, Moderna, Sanofi and China's CanSino Biologics.

 

As well as appearing safe and able to generate an immune response in animals, BBIBP-CorV did not appear to trigger antibodies that could boost the infection - a phenomenon known as antibody-dependent enhancement (ADE)- the researchers said, although this does not necessarily guarantee ADE won't occur in human tests.

 

Apart from BBIBP-CorV, Sinopharm, which has invested 1 billion yuan ($141.40 million) in vaccine projects, is testing in humans another vaccine candidate developed by its Wuhan-based unit. The two shots have been given to more than 2,000 people in clinical trials.

 

reuters_logo.jpg

-- © Copyright Reuters 2020-06-10
 
Posted
6 minutes ago, snoop1130 said:

The vaccine candidate, called BBIBP-CorV, induced high-level neutralising antibodies that can block the virus from infecting cells in monkeys, rats, guinea pigs and rabbits, researchers said in a paper published in online by the medical journal Cell on Saturday.

in other words, in all 1.4 billion of them (Chinese), good luck then

  • Like 1
Posted
2 hours ago, car720 said:

I was given a Longines watch by my Chinese friend the other day.  Fake of course.

Then it wasn't a Longines watch.

  • Like 2
Posted

When is a copy not a copy but considered an original, well that would only be when there is a power of attorney and all documents that are copies are certified as copies of an original.  So if you took a Longines watch and it was an exact duplicate with all the same parts would it be real or fake.

Posted
On 6/10/2020 at 12:08 PM, from the home of CC said:

if they're the first and come up with one that works and can produce it sufficient quantities they'll have the world by the cojones.. 

Its probably easier to come up with a fix for something that you made yourself in the first place

  • Haha 1

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...